Talaria Antibodies Inc, a spin-off company from LaCell LLC, was a semi-finalist in the Delta I-Fund Demo Day competition. Dr. Shawna Wicks, President and CEO of Talaria Antibodies, and her team completed the twelve week program which included customer discovery interviews with over 70 potential clients and product users. Talaria Antibodies, which was founded to produce polyclonal antibodies for the regenerative medicine and obesity research community, discovered an unmet need for its antibody based products as experimental teaching kits for the high school, junior college and undergraduate classroom. The Delta I-Fund is an early stage, proof-of-concept accelerator formed to train entrepreneurs in the eight-state Delta Regional Authority territory.